Description
Tretiheal (Tretinoin) 0.025% Cream
Tretiheal 0.025% cream contains tretinoin, a topical retinoid used in dermatology. Verified prescribing information for tretinoin cream identifies acne vulgaris as the established labeled use, and published reviews support its role in photoaging management.
Active Ingredient and Medicine Class
Active ingredient: tretinoin 0.025%. Tretinoin is all-trans-retinoic acid, a vitamin A derivative and first-generation retinoid. It is used as a topical dermatologic medicine.
Established Medical Uses
Official labeling supports tretinoin cream for the topical treatment of acne vulgaris. Scientific reviews also describe benefit in photoaged skin, including improvement in fine wrinkles and other visible signs of photodamage, although that use depends on the specific product and local approval status.
How It Works
Tretinoin helps regulate skin-cell turnover and differentiation. In acne, this reduces the formation of plugged pores and supports the clearing of comedonal lesions. In photoaging, topical tretinoin is thought to improve epidermal renewal and influence collagen-related changes in the skin.
Important Safety Information
Tretinoin cream should not be used in people with hypersensitivity to any ingredient. Labeling warns that it can cause irritation, redness, peeling, and increased sensitivity to sunlight, so sun exposure should be minimized. It should be used with caution on eczematous or sunburned skin and kept away from the eyes, mouth, and mucous membranes. Concomitant use with other products that increase irritation or photosensitivity may worsen local skin reactions.
Possible Side Effects
Common adverse effects include dryness, burning, stinging, erythema, peeling, and local irritation. Less common but more serious reactions include marked dermatitis, severe irritation, or intolerance requiring discontinuation. Photosensitivity and sunburn are important concerns.
Scientific Evidence
Peer-reviewed evidence supports topical tretinoin for acne and photoaging. A systematic review of randomized trials found consistent improvement in clinical signs of photoaged skin, and older controlled studies in acne showed benefit versus vehicle treatment. Recent reviews continue to describe tretinoin as a well-established topical retinoid in dermatology.
Medical Information Notice
This summary is for educational purposes only and is based on sources available at the time of review. It does not replace the official patient leaflet, prescribing information, or assessment by a qualified healthcare professional.
Medical Sources
- DailyMed / FDA label: Tretinoin Cream, 0.025% prescribing information. View source
- FDA: Tretinoin Cream, 0.025% label information. View source
- PubMed: Weiss JS et al. “Topical tretinoin in the treatment of aging skin.” J Am Acad Dermatol. 1988. View PubMed article